Nancy Reau to Hepatitis C
This is a "connection" page, showing publications Nancy Reau has written about Hepatitis C.
Connection Strength
2.870
-
Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017-2019. Adv Ther. 2021 12; 38(12):5777-5790.
Score: 0.732
-
Estimating the Year Each State in the United States Will Achieve the World Health Organization's Elimination Targets for Hepatitis?C. Adv Ther. 2021 01; 38(1):423-440.
Score: 0.684
-
HBV reactivation after HCV eradication: Deja Vu. Liver Int. 2017 07; 37(7):1088.
Score: 0.542
-
Generic medications for hepatitis C. Liver Int. 2016 07; 36(7):925-8.
Score: 0.506
-
Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS?CO13 HEPAVIH)". J Hepatol. 2020 03; 72(3):592-593.
Score: 0.161
-
Liver Diseases During Pregnancy. Clin Liver Dis. 2019 05; 23(2):345-361.
Score: 0.152
-
Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin. J Hepatol. 2012 Jun; 56(6):1276-82.
Score: 0.093